Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Polysomy

The condition of having additional copies of a chromosome present in a cell.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Approximately 8% of breast cancers show increased copy numbers of chromosome 17 centromere (CEP17) by fluorescence in situ… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE The occurrence of KRAS mutation is predictive of nonresponse and shorter survival in patients treated by anti-epidermal… Expand
  • table 1
  • figure 1
  • table 3
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The HER2 gene is an important prognostic and therapeutic marker in newly diagnosed breast cancer. Currently, HER2 status is most… Expand
  • table 2
  • table 1
  • figure 1
  • table 4
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE To investigate the prognostic role of genomic gain for MET and epidermal growth factor receptor (EGFR) genes in… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Polysomy 17 is frequently found in breast cancer and may complicate the interpretation of HER-2 testing results. We… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Hepatocellular carcinomas represent the third leading cause of cancer-related deaths worldwide. The vast majority of cases arise… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
To evaluate whether the epidermal growth factor receptor (EGFR), K-Ras and PTEN, all members of the EGFR signalling pathway, may… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
AIMS To investigate the correlation between centrally assessed human epidermal growth factor receptor 2 (HER2… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Gefitinib is a selective inhibitor of the epidermal growth factor (EGFR) tyrosine kinase, which is overexpressed in… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE The epidermal growth factor receptor (EGFR) is frequently overexpressed in non-small-cell lung carcinoma (NSCLC), and… Expand
Is this relevant?